Acute Glomerulonephritis: By: Jhaziel E. Bermejo

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 20

ACUTE

GLOMERULONEPHRITIS
By: Jhaziel E. Bermejo
INTRODUCTION
•DEFINITION
•CAUSES

•LABORATORY

•MANIFESTATIONS
DEFINITION
 Aka glomerular nephritis, (GN)
 is a renal disease characterized by inflammation of
the glomeruli, or small blood vessels in the
kidneys.
 refers to a specific set of renal diseases in which an
immunologic mechanism triggers inflammation
and proliferation of glomerular tissue that can
result in damage to the basement membrane,
mesangium, or capillary endothelium.
CAUSES
Post infectious etiologies
 Streptococcus species
 (i.e., group A, beta-hemolytic).
Systemic causes

 Vasculitis (ie, Wegener granulomatosis causes


glomerulonephritis that combines upper and lower
granulomatous nephritides).
 Collagen vascular diseases (ie, systemic lupus
erythematosus causes glomerulonephritis through
renal deposition of immune complexes).
 Cryoglobulinemia causes abnormal quantities of
cryoglobulin in plasma that result in repeated
episodes of widespread purpura and cutaneous
ulcerations upon crystallization.
 Polyarteritis nodosa causes nephritis from a
vasculitis involving the renal arteries.
 Henoch-Schönlein purpura causes a generalized
vasculitis resulting in glomerulonephritis.
 Goodpasture syndrome causes circulating
antibodies to type IV collagen and often results in
a rapidly progressive oliguric renal failure (weeks
to months).
 Drug-induced (ie, gold, penicillamine)
Renal diseases

 Idiopathic rapidly progressive glomerulonephritis


is a form of glomerulonephritis characterized by
the presence of glomerular crescents. Three types
have been distinguished.
 Type I is an antiglomerular basement membrane
disease,
 type II is mediated by immune complexes, and
 type III is identified by antineutrophil cytoplasmic
antibody.
Laboratory tests
 Antistreptolysin-O (ASO) Titer.
 Urinalysis.

 Renal Biopsy. Is the most confirmatory

diagnostic procedure.
 Electrolytes, including BUN and creatinine (to

estimate the glomerular filtration rate


[GFR]): The BUN and creatinine levels
will exhibit a degree of renal compromise.
 Complete blood cell count
 Streptozyme test
 Erythrocyte sedimentation ratio (ESR) usually is
increased.
 Urine or plasma creatinine level greater than 40;
decreased renin level is noted.
 Cultures of throat and skin lesions to rule out
Streptococcus species may be obtained.
 Blood cultures
 Imaging Studies
 Radiography
 Echocardiography
 renal ultrasonography
 CT scan
MANIFESTATIONS
 Nausea and vomiting  Hematuria
 fatigue and tiring  Hypertension
easily,  Generalized edema
 headaches,  Proteinuria
 twitchy movements  Oliguria
 mental confusion and  Anorexia
disorientation.
PATHOPHYSIOLOGY
Diagram presentation
MANAGEMENT
•Antibiotic and antihypertensive drugs
•Follow up care

•Patient teachings
MANAGEMENT
 Antibiotics.
 Antihypertensive.
 Bed rest.
 Increase oral fluid intake.
Antibiotic and antihypertensive drugs

Antibiotics
 The Penicillin is the DOC in treating acute
glomerulonephritis of a poststreptococcal group A
beta-hemolytic etiology.
 
 Penicillin V (Veetids)
 Inhibits enzymes and cell wall receptors, resulting in
cell wall synthesis inhibition. Other autolytics enzymes
are also activated, degrading the bacterial cell wall.
 Nonselective beta-blocker with cardioselective
alpha1 blocker
 Labetalol is used for hypertensive encephalopathy and
malignant hypertension.
 
 Labetalol (Normodyne)
 Has nonselective beta-antagonist and cardioselective
alpha1-antagonist effects. Beta-blocking effects
predominate, particularly when used IV. Low lipid
solubility means bioavailability is reduced by first pass
metabolism and enhanced by coadministration of food.
Drug is not removed by hemodialysis.
 Loop diuretics
 Loop diuretics are used for hypertensive encephalopathy
with CNS signs and circulatory congestion or pulmonary
edema. Furosemide is DOC for this indication.
 
 Furosemide (Lasix)
 Inhibits absorption of sodium and water in ascending limb
of loop of Henle by interfering with Na+/K+/Cl- channel. An
antihypercalcemic effect is mediated by an increased
excretion of calcium.
 Corticosteroids
 Methylprednisolone is used for nonstreptococcal
etiologies of acute glomerulonephritis, particularly in
lupus nephritis and in idiopathic progressive
glomerulonephritis.
 
 Methylprednisolone (Medrol)
 Has anti-inflammatory effect and is
immunosuppressive. Metabolized by hepatic
transformation and renal excretion.
Follow-up
Further Outpatient Care
 Urinalysis at 2, 4, and 6 weeks and at 4, 6, and 12

months
 Cessation of follow-up care when urinalysis is

normal
 Blood pressure monitoring during each visit

 Serum creatinine level monitoring at 2, 6, and 12

months
 Serum complement usually normal by 6 weeks
Patient Education
 Upon discharge from the ED, patient education should
emphasize the importance of close follow-up care.
 Indicate that strenuous exercise should be avoided
because exercise can induce proteinuria, hematuria,
and cylindruria (renal cylinders or casts in the urine) in
healthy individuals.
 Limit the patient to a diet with no added salt until
edema, hypertension, and azotemia clear.
 Restrict fluids in patients with significant edema.
 Restrict protein in the presence of azotemia and
metabolic acidosis (ie, approximately 0.5 g/kg/d).
 The patient should avoid high-potassium foods.

You might also like